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The eﬀect of antibiotics during the perioperative period of percutaneous dilatational tracheostomy 
(PDT) is still controversial.  A total of 297 patients who underwent the PDT procedure were divided 
into 2 groups: those administered antibiotics perioperatively and those not administered antibiotics.  
Wound infections were noted in 7 cases (incidence rate,  2.36ｵ) and no death was recorded.  Of the 69 
patients without antibiotics,  5 developed wound infections (incidence rate,  7.25ｵ),  while only 2 of the 
228 patients with antibiotics developed wound infections (incidence rate,  0.88ｵ) (p＝0.002; risk ratio,  
8.82; 95ｵ conﬁdence interval,  1.67-46.6).  Of the 7 cases of wound infection,  5 cases occurred during 
the early period after PDT (within 7 days).  Collectively,  the present results suggest that prophylactic 
administration of antibiotics may prevent the incidence of PDT-induced wound infection,  especially in 
the early phase after the PDT procedures.  The need for antibiotics in PDT should be reconsidered.
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racheostomy is a fundamental practice for long-
term airway management of critically ill 
patients.  Recently,  percutaneous dilatational tracheo-
stomy (PDT) has been widely used and is preferred to 
surgical tracheostomy (ST),  since it is easier to per-
form and requires less time [1-5],  yields fewer 
complications (e.g.,  hemorrhage,  pneumothorax,  and 
tracheal stenosis) [6,  7] including infection [8-11],  
produces cosmetically better results [12],  is more 
cost-eﬀective [3,  7,  13],  and results in a lower 
mortality rate [1].
　 Wound infection related to PDT can be lethal or 
may require long-term treatment for critically ill 
patients.  However,  antibiotics are generally not admin-
istered during the perioperative period of the tracheo-
stomy because at present there is scant evidence of 
their eﬀectiveness [12].  We investigated whether 
administration of antibiotics during the perioperative 
period of PDT would reduce the incidence of wound 
infection.
Materials and Methods
　 Study subjects. This single-center retrospec-
tive study was conducted in the open-type combined 
medical/surgical intensive care unit (ICU) of Tsuyama 
Central Hospital,  Okayama,  Japan.  The present study 
(No. 167) was approved by the Institutional Review 
Board (IRB) of Tsuyama Central Hospital.
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　 PDT procedure and administration of antibi-
otics. The study period was between January 1st,  
2004 and March 31st,  2011.  The participants were 
critically ill adult patients (older than 20 years of age) 
who were admitted to our ICU for any reason and 
judged by at least 2 intensivists to be in need of tra-
cheostomy.  Among the patients,  those with contrain-
dications for PDT such as anatomical abnormality 
were excluded.  PDT was performed according to the 
Ciaglia Blue Rhino technique (NEO PERC,  Covidien,  
Japan) with bronchoscope assistance (Fig.  1).
　 Surgical site infection (SSI) is generally diagnosed 
by inﬂammatory changes such as tenderness,  swelling,  
or redness around the surgical site within 30 days 
after a surgical procedure [14].  In this study,  we 
deﬁned a wound infection after PDT as infection-
induced inﬂammatory changes at the tracheostomy site 
within 30 days after PDT,  accompanied by systemic 
fever,  pustular discharge,  redness or tenderness.
　 The patientsʼ medical records were checked retro-
spectively to determine whether any antibiotics were 
administered on the day of PDT.  Patients who 
received and those who did not receive antibiotics 
were classiﬁed into an Abx (antibiotics) group and 
Non-Abx (non-antibiotics) group,  respectively.  We 
investigated wound infection (rate),  length of ICU stay 
after tracheostomy,  overall ICU stay,  period of hos-
pital stay after tracheostomy,  and number of deaths 
related to wound infection.  The early period after 
PDT was deﬁned as the ﬁrst 7 days after the proce-
dure.
　 Statistical analysis. Data were analyzed using 
SPSS version 17.0.  Variables were compared with 
the t test and χ2 test with Yatesʼ continuity correction.  
The level of signiﬁcance was set at p＜0.05.
Results
　 PDT was performed in 385 patients.  Eighty-eight 
patients were excluded since they died due to primary 
diseases within 30 days after PDT.  There was no 
death caused by PDT-related complications.  Thus the 
data for 297 cases were included in the ﬁnal analysis 
(Fig.  2).
　 The major underlying disease on admission to the 
ICU was neurological disorders,  followed by trauma 
and respiratory failure (Table 1).  Overall,  the Non-
Abx group consisted of 69 patients (34 men and 35 
women; mean age,  70.4 years; age range,  29 to 91 
years) and the Abx group consisted of 228 patients 
(160 men and 68 women; mean age,  70.5 years; age 
range,  32 to 98 years).  The percentage of males was 
signiﬁcantly greater in the Abx-group.  Serum albumin 
and C-reactive protein (CRP) levels before PDT,  the 
timing of PDT after admission to the hospital,  and the 
duration of endotracheal intubation prior to tracheos-
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Fig. 1　 The percutaneous dilatational tracheostomy (PDT) kit used in this study.  1) Puncture needle; 2) Guide wire; 3) 1st dilator; 4) 2nd 
dilator; and 5) Cuﬀed tracheostomy tube (NEO PERC,  Tyco Healthcare,  Tokyo,  Japan).  The items are numbered in their order of use 
during the procedure.
tomy were not signiﬁcantly diﬀerent between the 2 
groups.  Among patients with neurological disorders,  
males outnumbered females.  Moreover,  the serum 
albumin and the CRP level of the Abx group were 
signiﬁcantly diﬀerent compared to those of the Non-
Abx group.  Among patients with trauma,  the CRP 
level was higher in the Abx group.  A summary of the 
baseline characteristics of the patients in the Abx,  
Non-Abx and various subgroups is shown in Table 2.
　 Various antibiotics,  such as penicillins (used in 
25.5ｵ of cases; ampicillin,  ampicillin/sulbactam,  
piperacillin,  and piperacillin/tazobactam),  cephems 
(22.9ｵ; cefazolin,  cefotiam,  cefmetazole,  ceftriax-
one,  cefotaxim,  ceftazidime,  cefepime,  and cefopera-
zon/sulbactam),  anti-MRSA drugs (14.7ｵ; vancomycin,  
teicoplanin,  arbekacin,  and linezolid) were adminis-
tered perioperatively to treat primary infections in 
each patient.
　 The main results are shown in Fig.  3.  Overall,  
wound infection was noted in 7 patients (Fig.  3A).  
The total incidence rate of wound infection was calcu-
lated as 2.36ｵ.  Of the 69 patients in the Non-Abx 
group,  5 developed wound infection (incidence rate,  
7.25ｵ),  while 2 of the 228 patients in the Abx group 
developed wound infection (incidence rate,  0.88ｵ) 
(p＝0.002; risk ratio,  8.82; 95ｵ conﬁdence interval 
(C.I.): 1.67-46.6).  Remarkably,  there were 2 wound 
infection cases in the post-operation group,  which was 
signiﬁcantly diﬀerent from the incidence in the Non-
Abx group.  The 2 cases of wound infection in the Abx 
group were both trauma patients.  Five patients had 
wound infection in the early period after PDT,  and all 
of these patients belonged to the Non-Abx group (Fig.  
3B).  In the post-operation category,  the incidence 
rate of wound infection was also signiﬁcantly higher in 
the Non-Abx group.  Other outcomes including length 
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Table 1　 Underlying disorders for ICU admission
Non-Abx group (%) Abx group (%) Total (%)
Neurological disorders 27 (39.1) 89 (39.0) 116 (39.1)
Trauma 7 (10.1) 36 (15.8) 43 (14.5)
Respiratory failure 7 (10.1) 35 (15.4) 42 (14.1)
#Post-operation 7 (10.1) 27 (11.8) 34 (11.4)
Cardiopulmonary arrest 10 (14.5) 20 (8.3) 30 (9.8)
Cardiac failure 4 (5.8) 7 (3.1) 11 (3.7)
Sepsis 2 (2.9) 7 (3.1) 9 (3.0)
Airway obstruction 2 (2.9) 4 (1.8) 6 (2.0)
Burn 1 (1.4) 1 (0.4) 2 (0.7)
Renal failure 1 (1.4) 1 (0.4) 2 (0.7)
Intoxication 1 (1.4) 1 (0.4) 2 (0.7)
Total 69 228 297
#A detail of post-operation group included cardiovascular surgery (19 cases),  gastrointestinal surgery (10 cases),  thoracic surgery (3 
cases),  head and neck surgery (1 case),  and orthopedic surgery (1 case).
PDT in 385 patients
Analyzed: 297 cases
Non-Abx group
69 cases
Abx group
228 cases
Excluded: 88 cases
5 infection cases 2 infection cases
Fig. 2　 Flow diagram of the present study.  Among the 88 
excluded cases,  there was no case with PDT-related complica-
tions.  PDT: percutaneous dilatational tracheostomy; Abx 
group: antibiotics group; and Non-Abx group: non-antibiotics 
group.
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Fig. 3　 The occurrence of wound infection after PDT in each group.  Panels A and B show the total number of wound infections and the 
number of wound infections within 7 days,  respectively.  Statistical analysis was performed using chi-square test (Fisherʼs exact test) with 
Yatesʼ continuity correction.  Overall,  the occurrence of wound infection was signiﬁcantly increased in both all subjects (A) and early-
period subjects (B) of the Non-Abx group.  The same tendency was conﬁrmed in the Post-operation group.  ＊p＜0.05 and ＊＊p＜0.01 for the 
comparison with the Non-Abx group.
Table 2　 Baseline characteristics of the patients
Overall (n＝297)
Neurologic disorders
(n＝116)
Trauma (n＝43) Respiratory failure (n＝42) Post-operation (n＝34) CPA (n＝30)
Non-Abx
(n＝69)
Abx
(n＝228)
Non-Abx
(n＝27)
Abx
(n＝89)
Non-Abx
(n＝7)
Abx
(n＝36)
Non-Abx
(n＝7)
Abx
(n＝35)
Non-Abx
(n＝7)
Abx
(n＝27)
Non-Abx
(n＝10)
Abx
(n＝20)
Male/Female 34/35 160/68＊＊ 11/16 61/28＊＊ 4/3 28/8 5/2 21/14 3/4 21/6 4/6 11/9
Age (years) 70.4±12.0 70.5±13.3 67.9±12.9 67.9±13.8 67.7±17.7 68.0±16.1 67.7±10.8 75.6±10.5 78.4±4.0 75.3±11.8 73.5±12.4 67.6±10.6
Albumin (g/dL)  2.7±0.73  2.5±0.64 3.0±0.7  2.7±0.7＊ 2.7±0.7 2.4±0.5 2.6±0.6 2.4±0.5 2.7±0.8 2.6±0.6 2.3±0.8 2.5±0.8
CRP (mg/dL) 5.8±4.3 8.4±6.8 5.1±3.2 　8.8±7.9＊＊ 4.8±4.0  9.7±5.3＊ 5.0±4.1 8.5±6.9 8.3±4.9 6.5±5.4 7.0±6.0 6.8±6.0
PDT after
admission (days)
20.7 (2-108) 16.9 (0-247) 17.9 (1-103) 14.8 (1-165) 7.9 (2-14) 16.6 (0-112) 19.4 (10-39) 13.1 (0-56) 34.7 (13-71) 30.9 (0-247) 12.2 (5-29) 9.8 (1-23)
Intubation prior
to PDT (days)
11 (0-43) 9.9 (0-42) 11.1 (0-43) 9.1 (0-34) 4.7 (0-10) 10.8 (0-42)＊ 12.9 (1-26) 7.6 (0-24) 14.6 (0-32) 12.6 (0-37) 10 (0-29) 9.7 (1-23)
CPA,  Cardiopulmonary arrest; and CRP,  C-reactive protein.  Data of age,  albumin,  and CRP are shown as mean ±  standard deviation.  
＊P＜0.05 and ＊＊P＜0.01 for the comparison with the Non-Abx group.  In total,  male patients outnumbered female.  The tendency was also 
seen in the group of neurologic disorders.  Serum albumin level was lower in Abx group of neurologic disorders,  and serum CRP level was 
lower in both the Abx group of Neurologic disorders and Trauma.
of ICU stay after tracheostomy,  overall ICU stay,  and 
the periods of hospital stay after tracheostomy were 
not signiﬁcantly diﬀerent between the 2 groups.  Of 
the 7 patients with wound infection,  no death or fatal 
wound infection such as mediastinitis was recorded.  
The summary of wound infection cases is shown in 
Table 3.
Discussion
　 The validity of prophylactic administration of 
antibiotic remains a matter of debate.  As for general 
surgery,  the administration of prophylactic antibiotics 
is known to reduce the incidence of SSI [14-16].  
However,  to the best of our knowledge,  there is no 
clear evidence regarding the eﬃcacy of prophylactic 
antibiotics in preventing wound infections after PDT 
[12].  A meta-analysis of 6 prospective studies revealed 
that PDT causes less wound infection than ST does 
(odds ratio with 95ｵ C.I.,  0.02 [0.01-0.07]) [1].  
However,  the incidence rate of wound infection after 
PDT is still high: 6ｵ to 7ｵ in a previous study [9] 
and 7.25ｵ in the Non-Abx group of this study.  
Patients who receive PDT in the ICU are generally 
critically ill,  and wound infection can increase the 
mortality rate,  extend the length of ICU stay,  and 
give rise to additional costs.
　 As mentioned above,  the superiority of PDT over 
ST from various points of view has been established.  
The superiority of PDT can be attributed to diﬀer-
ences in the degree of dead space and tissue destruc-
tion.  ST results in a large dead space around the 
tracheostomy cannula,  while PDT produces less space 
between the tube and the stomal tissue since the ﬁtting 
is tight with the surroundings.  Less local tissue 
destruction and consequently decreased exposure of 
raw skin surfaces after PDT is another possible rea-
son for the lower incidence of infection [9].
　 The pathogens responsible for wound infections 
after tracheostomy are considered to be normal bacte-
rial ﬂora of the skin,  bronchial mucosa,  or oral cavity 
such as Staphylococcus spp.  and Streptococcus spp..  
Various kinds of antibiotics such as β-lactams (i.e.,  
penicillins and cephems),  anti-MRSA drugs,  and ﬂuo-
roquinolones were used in this study,  and these drugs 
generally have antibacterial activity against these 
pathogens.  This is also a possible reason for the 
lower rate of wound infection in the Abx group.
　 Of the 7 cases of wound infection,  5 cases occurred 
in the early phase,  and all of these belonged to the 
Non-Abx group.  In the Abx group,  there were 2 cases 
of infection,  but both occurred more than 2 weeks 
after PDT: on days 18 and 27.  Thus,  prophylactic 
antibiotics may be eﬀective for preventing wound 
infections in the early phase but have little eﬀect in 
the late phase.  In the early phase after surgical inter-
vention,  the tissue is damaged and vulnerable to 
infection.  We assume that antibiotics can prevent the 
damaged tissue from being infected in the early 
phase; on the other hand,  the preventive eﬀect of 
prophylactic antibiotics is reduced in the later stage.
　 The antibiotics were administered not as prophy-
laxis but as treatment of primary infections in this 
study,  and it is therefore diﬃcult to draw a conclu-
sion regarding the preventive eﬃcacy.  The use of 
antibiotics may lead to a potential risk of emergence 
of antibiotic-resistant bacteria or the occurrence of 
Clostridium diﬃcile infection.  However,  the doses and 
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Table 3　 Summary of wound infection cases
Case Sex/age Antibiotics Occurrence Underlying disorders Intervention Antibiotics for treatment (duration) Prognosis
Abx
group
1 Male/77 Flomoxef,
Ciproﬂoxacin
Day 27 Trauma none Azithromycin,  0.5g (one day) Cured
2 Female/80 Cefazolin Day 18 Trauma none none Cured
Non 
Abx 
group
3 Male/79 none Day 5 Post operation Surgical drainage Cefepime,  2g/day (5 days) Cured
4 Male/74 none Day 7 Post operation none Cefcapene pivoxil,  300mg/day (21 days) Cured
5 Female/71 none Day 5 CPA Otolaryngologist
consultation
Amoxicillin/clavulanate,  
1,125mg/day (14 days) Cured
6 Male/53 none Day 7 Neurological disorder none none Cured
7 Male/80 none Day 5 Trauma none Ampicillin/sulbactam 9g/day
＋Vancomycin 2g/day (5 days) Cured
CPA,  cardiopulmonary arrest.
durations of antibiotics needed for prophylaxis would 
be less than those needed for treatment.  Hence,  the 
negative eﬀect of prophylactic antibiotics would be 
trivial.  Nevertheless,  ICU patients always include a 
wide variety of clinical disorders involving multi-organ 
damages and possible latent infections.  It is therefore 
very hard to draw deﬁnitive conclusions regarding the 
timing,  dose and selection of antibiotics from the 
results of this retrospective study.  In the future,  a 
large prospective randomized trial will be needed to 
conﬁrm our present results.
　 In conclusion,  the present results suggest that the 
eﬀectiveness of prophylactic antibiotics for reducing 
the incidence of wound infection in PDT must be 
reconsidered,  and that the indication for such treat-
ment will involve consideration of the disease category 
and the clinical condition.
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